A randomised double-blind placebo-contro
β
P. Loiseau; A.W.C. Yuen; B. Duché; T. Ménager; M.C. Arné-Bès
π
Article
π
1990
π
Elsevier Science
π
English
β 874 KB
Efficacy and safety of lamotrigine (LTG) as add-on therapy was assessed in a randomised double-blind placebo-controlled trial of this drug in 23 adult patients with refractory partial seizures. Fifteen patients showed an improvement on LTG treatment, with a greater than 50% decrease in total seizure